Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
This trial is to determine the effect of Tranexamic Acid (TXA) on blood loss during
endoscopic pituitary surgery. The hypothesis of this study is that TXA will reduce blood loss
during surgery compared to a placebo. To answer this hypothesis, the investigators are
conducting a randomized controlled trial in which half of participants will receive TXA and
half will receive placebo (saline) in a double blind fashion.